International Biotechnology Trust (LSE:IBT) Change In Receivables: £-0.13 Mil (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:IBT International Biotechnology Trust PLC LSE:IBT
36 GF Score
Price £11.05
! 4 Warning Signs
View Full Analysis

What is International Biotechnology Trust Change In Receivables?

International Biotechnology Trust LSE:IBT +1.84% 36 Change In Receivables is £-0.13 Mil as of Feb. 2026. GuruFocus rates LSE:IBT with a GF Score™ of 36/100. The stock has 4 warning signs investors should review.

International Biotechnology Trust's change in receivables for the quarter that ended in Feb. 2026 was £-0.12 Mil. It means International Biotechnology Trust's Accounts Receivable increased by £0.12 Mil from Aug. 2025 to Feb. 2026 .

International Biotechnology Trust's change in receivables for the fiscal year that ended in Aug. 2025 was £0.01 Mil. It means International Biotechnology Trust's Accounts Receivable declined by £0.01 Mil from Aug. 2024 to Aug. 2025 .

International Biotechnology Trust's Accounts Receivable for the quarter that ended in Feb. 2026 was £0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. International Biotechnology Trust's Days Sales Outstanding for the six months ended in Feb. 2026 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. International Biotechnology Trust's liquidation value for the six months ended in Feb. 2026 was £-29.00 Mil.

International Biotechnology Trust  (LSE:IBT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

International Biotechnology Trust's Days Sales Outstanding for the quarter that ended in Feb. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/85.739*91
=0.00

2. In Ben Graham's calculation of liquidation value, International Biotechnology Trust's accounts receivable are only considered to be worth 75% of book value:

International Biotechnology Trust's liquidation value for the quarter that ended in Feb. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2.968-31.963+0.75 * 0+0.5 * 0
=-29.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust Change In Receivables Related Terms

International Biotechnology Trust Change In Receivables Historical Data

* Premium members only.

The historical data trend for International Biotechnology Trust's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust Change In Receivables Chart

International Biotechnology Trust Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.78 -0.03 -0.03 0.01 0.01

International Biotechnology Trust Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 0.06 0.02 -0.01 -0.12
LSE:IBT
36GF Score
International Biotechnology Trust PLC LSE:IBT
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

International Biotechnology Trust Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of £-0.13 Mil mean?
International Biotechnology Trust (LSE:IBT) has a Change In Receivables of £-0.13 Mil as of Feb. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for International Biotechnology Trust and its competitors.
Is International Biotechnology Trust's Change In Receivables too high?
International Biotechnology Trust's current Change In Receivables is £-0.13 Mil. Overall, International Biotechnology Trust has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's Change In Receivables compare to VRTX and REGN?
International Biotechnology Trust's Change In Receivables of £-0.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for International Biotechnology Trust and its competitors. International Biotechnology Trust's current Change In Receivables is £-0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current Change In Receivables of £-0.13 Mil. The current Change In Receivables is £-0.13 Mil. International Biotechnology Trust's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current Change In Receivables is £-0.13 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

International Biotechnology Trust Business Description

Address 1 London Wall Place, London, GBR, EC2Y 5AU
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
36GF Score

Get the complete analysis for LSE:IBT

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£11.05
Price